In an effort to provide Physicians and Technologists with current information and data to make informed decisions in their clinical settings, this symposium covers several areas. Current topics related to the use of MR contrast agents, specifically the options and complexity of MR contrast agent administration. Gadolinium agents are not all the same with respect to relaxivity, efficacy and safety. This educational webinar will serve as a discussion to understanding the benefits of Macrocyclic versus Linear GBCA and the current updates on Gadolinium Retention.
- Address considerations in administering MR GBCAs.
- Discuss the scientific updates on Gadolinium Retention.
- Review the benefits of Macrocyclic GBCAs and safety.
- Discuss the current state of MR today.
This webinar is specifically designed for Technologists, and other healthcare professionals.
0.75 hour of Category A CE credit is pending approval by the ASRT. This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a live activity for credit if it was reported in the same or any subsequent biennium.
Release Date: 6/24/2020 | Expires: 7/1/2021
Faculty and Planner Disclosures:
In accordance with this policy, faculty and planners must disclose any financial relationships with commercial interests germane to program content. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of NWIF to ensure that the COI is resolved in order to ensure the integrity of the CME/CE activity. The planner has nothing to disclose
Emanuel Kanal, MD, FACR, FISMRM, MRMD, MRSE, AANG
- General Electric Healthcare – Speaking Fee
- Bracco Diagnostics Inc. – Speaking Fee